Literature DB >> 10476862

Synthesis and antitumoral activities of marine ent-chromazonarol and related compounds.

A F Barrero1, E J Alvarez-Manzaneda, M M Herrador, R Chahboun, P Galera.   

Abstract

Efficient syntheses of ent-isozonarol (6a), ent-isozonarone (7a) and ent-chromazonarol (8) from (-)-sclareol (12) are described. 6a and 7a show a significative antitumoral activity.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10476862     DOI： 10.1016/s0960-894x(99)00382-0

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN： 0960-894X            Impact factor:   2.823


  6 in total

1.  Oxidative degradations of the side chain of unsaturated ent-labdanes. Part I.

Authors:  Luis Espinoza Catalán; Héctor Carrasco Altamirano; Mauricio Cuellar Fritis; Claudio Gallardo Araya; Karen Catalán Marín
Journal:  Molecules       Date:  2007-03-06       Impact factor: 4.411

Review 2.  Reactivity and biological activity of the marine sesquiterpene hydroquinone avarol and related compounds from sponges of the order Dictyoceratida.

Authors:  Dusan Sladić; Miroslav J Gasić
Journal:  Molecules       Date:  2006-01-31       Impact factor: 4.411

3.  Oxidative degradations of the side chain of unsaturated ent-labdanes. Part II.

Authors:  Luis Espinoza Catalán; Karen Catalán Marín; Héctor Carrasco Altamirano; Mauricio Cuellar Fritis; María Cristina Chamy
Journal:  Molecules       Date:  2007-12-21       Impact factor: 4.411

Review 4.  Cytotoxic terpene quinones from marine sponges.

Authors:  Marina Gordaliza
Journal:  Mar Drugs       Date:  2010-11-24       Impact factor: 5.118

Review 5.  Synthetic strategies to terpene quinones/hydroquinones.

Authors:  Marina Gordaliza
Journal:  Mar Drugs       Date:  2012-02-14       Impact factor: 6.085

Review 6.  Meroterpenes from marine invertebrates: structures, occurrence, and ecological implications.

Authors:  Marialuisa Menna; Concetta Imperatore; Filomena D'Aniello; Anna Aiello
Journal:  Mar Drugs       Date:  2013-05-17       Impact factor: 5.118
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.